 | This articlemay be too technical for most readers to understand. Pleasehelp improve it tomake it understandable to non-experts, without removing the technical details.(June 2015) (Learn how and when to remove this message) |
 | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H21FN2O |
| Molar mass | 360.432 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
FUBIMINA (also known asBIM-2201,BZ-2201 andFTHJ) is a syntheticcannabinoid that is thebenzimidazoleanalog ofAM-2201[1] and has been used as an active ingredient insynthetic cannabis products.[2] It was first identified in Japan in 2013, alongsideMEPIRAPIM.[3]
FUBIMINA acts as a reasonably potentagonist for theCB2 receptor (Ki = 23.45 nM), with 12x selectivity overCB1 (Ki = 296.1 nM), and does not fully substitute forΔ9-THC in rat discrimination studies.[4]
Related benzimidazole derivatives have been reported to be highly selectiveagonists for theCB2 receptor.[5]
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
